Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with estrogen receptor positive (hormone-sensitive) breast cancer significantly reduces the risk of ...
UPTON, NY - A study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory has demonstrated that a molecule "tagged" with a radioactive form of carbon can be used to image aromatase, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results